RichardMDubinskyMDMPH

Neurology • Kansas City, KS

Neurophysiology

Professor, Neurology, University Kansas School of Medicine

Join to view full profile

Dr. Dubinsky is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Dubinsky's full profile

Already have an account?

Office
3599 Rainbow Blvd
Kansas City, KS 66103
Phone+1 913-588-6970

Fax+1 913-588-6965

Education & Training

University of FloridaFellowship, Clinical Neurophysiology, 2011 - 2012
Clinical Center at the National Institutes of HealthResidency, Neurology, 1986 - 1988
Baylor College of MedicineResidency, Neurology, 1983 - 1986
Baylor College of MedicineInternship, Internal Medicine, 1982 - 1983
University of Missouri Kansas City School of MedicineClass of 1982

Certifications & Licensure

MO State Medical License 2003 - 2026
KS State Medical License 1988 - 2025
OK State Medical License 2020 - 2021
TX State Medical License 1983 - 1988
American Board of Psychiatry and Neurology Neurology
American Board of Psychiatry and Neurology Clinical Neurophysiology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Super Doctor SuperDoctors.com

Clinical Trials

Study of Memantine to Treat Huntington's Disease Start of enrollment: 2004 Nov 23
Completed
Phase 4

Publications & Presentations

PubMed

Predicting Driving Cessation in Alzheimer Disease: Performance Beats Biomarkers.
Richard M Dubinsky, Anthony C Stein
Neurology. 2024-06-25
17 citations
Aducanumab Use in Symptomatic Alzheimer Disease Evidence in Focus: A Report of the AAN Guidelines Subcommittee.
Gregory S Day, Nikolaos Scarmeas, Richard Dubinsky, Katherine Coerver, Anitra Mostacero
Neurology. 2022-04-12
2 citations
Gene-Environment Interactions in Progressive Supranuclear Palsy.
Irene Litvan, James A. Proudfoot, Eden R. Martin, David G. Standaert, David E. Riley
Frontiers in Neurology. 2021-04-09

Press Mentions

Local Scientific Discovery Could Lead to Better Treatments for Huntington’s and Other DiseasesJuly 2nd, 2023
What Factors Predict When Older Adults Will Stop Driving?May 23rd, 2024
When Should Old People Stop Driving?May 24th, 2024